Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Table 1 SRI's used by subjects for failed treatment trial prior to inclusion in the study.

Drug	N	Mean maximum tolerated dose (mg/day)	Median daily dose (mg/day)	Range
Fluoxetine	13	60	60	60
Citalopram	10	61	60	10
Paroxetine	4	65	60	20
Fluvoxamine	10	290	300	100
Sertraline	1	200	200	0
Clomipramine	2	250	250	0

ISSN: 1471-244X